Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
USL for Dry Eye Disease
NCT06016010Phase 2Not yet recruiting
- Start
- Jan 2024
- Primary completion
- Dec 2025
01
Overview
Phase 2, randomised, double-blind trial of USL in dry eye disease (DED) (3 arms). Primary endpoint: Tear break-up time at 14 weeks. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
USL
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06016010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06016010.